NLC Health Ventures and Minnesota MedTech 3.0 Forge Strategic Partnership

Amsterdam, Friday, 21 February 2025.
The collaboration connects European medtech startups to Minnesota, aiming to expand market reach and drive innovation in medical technology through strategic investments and partnerships.
Strategic Alliance in Medical Technology
On February 19, 2025, NLC Health Ventures, a Dutch venture builder, and Minnesota MedTech 3.0 (MMT3.0) established a groundbreaking partnership to advance medical technology innovation [1][2]. This medtech-focused collaboration brings together over 20 entities, including the Mayo Clinic and Minnesota state leadership, creating a powerful ecosystem for healthcare technology development [1]. Based in Amsterdam, NLC Health Ventures brings significant experience with their portfolio of 70 startups across 16 countries [1].
Integration and Expansion Plans
The partnership includes concrete plans for NLC’s integration into the MMT3.0 ecosystem, encompassing crucial areas such as design, testing, clinical research, and regulatory pathways [1]. A key component of this collaboration is NLC’s exploration of establishing a physical presence in Minnesota for its U.S. platform office [1][2]. The partnership was formalized through a memorandum of understanding signed in Amsterdam, with key figures including Minnesota Governor Tim Walz and GREATER MSP President Peter Frosch present at the signing [2].
Investment and Economic Impact
Both organizations are exploring the creation of a joint investment fund to accelerate NLC’s presence and portfolio companies in Minnesota [1]. This initiative aligns with Minnesota’s designation as the U.S. Tech Hub for medical technology, positioning the state to attract significant private capital and create new jobs [2]. As Patrick Seeb, Executive Director of Destination Medical Center notes, ‘Minnesota is an ideal U.S. market entry point for fast-growing international HealthTech companies’ [1].
Future Outlook and Benefits
The collaboration aims to transform Rochester, Minnesota into ‘America’s City for Health’ through a comprehensive 20-year development plan [1]. Bert Arjan Millenaar, Founder & CEO of NLC Health Ventures, emphasized Minnesota’s position as ‘one of the world’s leading MedTech hubs,’ highlighting existing collaborations with institutions like Mayo Clinic and Medtronic [1]. This partnership represents a significant step in creating a transatlantic bridge for medical technology innovation, potentially opening new opportunities for European startups in the American market [1][2].